Background Evidence‐based recommendations for antithrombotic treatment in patients who
have an indication for oral anticoagulation (OAC) after transcatheter edge‐to‐edge mitral …

Transcatheter edge-to-edge mitral valve repair (TEER) has become established as a safe
and efficacious therapy for severe mitral regurgitation (MR) in high-risk patients. Despite its …

Aims This study sought to investigate current anticoagulatory treatment patterns and clinical
outcome in patients undergoing transcatheter mitral valve repair (MitraClip). Methods and …

Purpose The optimal antithrombotic strategy after transcatheter valve interventions is a
subject of ongoing debate. Although there is evidence from randomized trials in patients …

Incidence of stroke within 30 days after percutaneous mitral valve repair using the MitraClip
varies from 0.7% and 2.6% between registries. Standard medical treatment after the …

Background The recommendations for antithrombotic therapy after a transcatheter edge-to-
edge mitral valve repair (TEER) remain empirical, and the benefit of antiplatelet (APT) or …

Background: Incidence of stroke within 30 days after percutaneous mitral valve repair using
the MitraClip varies from 0.7% and 2.6% between registries. Standard medical treatment …

1. Hohnloser SH, Kuck KH, Dorian P. Prophylactic use of an implantable cardioverter-
defibrillator after acute myocardial infarction. N Engl J Med 2004; 351: 2481–2488 …

Background: In patients undergoing transcatheter mitral valve edge-to-edge repair using
MitraClip system, it is to be expected that late bleeding event will be frequent and affect …

Bleeding after cardiac surgery or cardiovascular interventions is associated with worse
patient outcome. Only very limited data are available on the subject of bleeding after …